We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Molina Healthcare (MOH) Closes $150M My Choice Wisconsin Buyout
Read MoreHide Full Article
Molina Healthcare, Inc. (MOH - Free Report) announced that the My Choice Wisconsin buyout closed on Sep 1, 2023, a tad before its updated scheduled time. The deal was first announced in July 2022 and was expected to close last year. However, with second quarter 2023 earnings, it said that the deal was expected to close in the fourth quarter of this year.
The acquisition is expected to have cost the company around $150 million, net of expected tax benefits and regulatory capital and add to its Medicaid and Medicare businesses’ strength. The acquiree served more than 44,000 members as of Jun 30, 2023. The buyout of the Medicaid managed care organization will boost Molina Healthcare’s footprint in the region.
This reflects the company's impressive inorganic growth strategy, which is backed by its strong financial position. Its cash and cash equivalents at the second quarter-end were $4.9 billion, significantly higher than the long-term debt of only $2.2 billion. Also, it generated ample cash. During the first half of 2023, net cash provided by operating activities surged 91.9% year over year.
Its list of latest acquired companies includes the Magellan Complete Care line of business of Magellan Health, substantially all the assets of Affinity Health Plan, Texas Medicaid and Medicare-Medicaid Plan contracts and specific operating assets of Cigna, certain assets of YourCare and Passport, and others.
There’s more on the way. MOH agreed to buy all the issued and outstanding capital stock of CA Health Plans from Bright Health Company of California, Inc. on Jun 30, 2023. The $510 million deal is expected to close by the first quarter of next year and add to its Medicare business strength.
Price Performance
MOH shares have climbed 13.1% in the past six months compared with the 1.3% increase in the industry.
The Zacks Consensus Estimate for Select Medical’s 2023 earnings indicates a 56.9% year-over-year increase to $1.93 per share. It has witnessed one upward estimate revision over the past month against no movement in the opposite direction. The consensus mark for SEM’s 2023 revenues indicates 4.2% growth from a year ago.
The Zacks Consensus Estimate for HCA Healthcare’s 2023 bottom line suggests a 9.2% increase from the prior-year levels. HCA has witnessed two upward estimate revisions in the past month against none in the opposite direction. It beat earnings estimates in three of the last four quarters and missed once, with the average surprise being 5.4%.
The Zacks Consensus Estimate for Atai Life Sciences’ current-year earnings implies a 16.3% improvement from the year-ago reported figure. It has witnessed four upward estimate revisions over the past month against no movement in the opposite direction. ATAI beat earnings estimates in two of the last four quarters, met once and missed on one occasion.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Molina Healthcare (MOH) Closes $150M My Choice Wisconsin Buyout
Molina Healthcare, Inc. (MOH - Free Report) announced that the My Choice Wisconsin buyout closed on Sep 1, 2023, a tad before its updated scheduled time. The deal was first announced in July 2022 and was expected to close last year. However, with second quarter 2023 earnings, it said that the deal was expected to close in the fourth quarter of this year.
The acquisition is expected to have cost the company around $150 million, net of expected tax benefits and regulatory capital and add to its Medicaid and Medicare businesses’ strength. The acquiree served more than 44,000 members as of Jun 30, 2023. The buyout of the Medicaid managed care organization will boost Molina Healthcare’s footprint in the region.
This reflects the company's impressive inorganic growth strategy, which is backed by its strong financial position. Its cash and cash equivalents at the second quarter-end were $4.9 billion, significantly higher than the long-term debt of only $2.2 billion. Also, it generated ample cash. During the first half of 2023, net cash provided by operating activities surged 91.9% year over year.
Its list of latest acquired companies includes the Magellan Complete Care line of business of Magellan Health, substantially all the assets of Affinity Health Plan, Texas Medicaid and Medicare-Medicaid Plan contracts and specific operating assets of Cigna, certain assets of YourCare and Passport, and others.
There’s more on the way. MOH agreed to buy all the issued and outstanding capital stock of CA Health Plans from Bright Health Company of California, Inc. on Jun 30, 2023. The $510 million deal is expected to close by the first quarter of next year and add to its Medicare business strength.
Price Performance
MOH shares have climbed 13.1% in the past six months compared with the 1.3% increase in the industry.
Image Source: Zacks Investment Research
Zacks Rank & Other Key Picks
Molina Healthcare currently has a Zacks Rank #2 (Buy). Some other top-ranked stocks in the broader medical space are Select Medical Holdings Corporation (SEM - Free Report) , HCA Healthcare, Inc. (HCA - Free Report) and Atai Life Sciences N.V. (ATAI - Free Report) , each carrying a Zacks Rank #2 at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for Select Medical’s 2023 earnings indicates a 56.9% year-over-year increase to $1.93 per share. It has witnessed one upward estimate revision over the past month against no movement in the opposite direction. The consensus mark for SEM’s 2023 revenues indicates 4.2% growth from a year ago.
The Zacks Consensus Estimate for HCA Healthcare’s 2023 bottom line suggests a 9.2% increase from the prior-year levels. HCA has witnessed two upward estimate revisions in the past month against none in the opposite direction. It beat earnings estimates in three of the last four quarters and missed once, with the average surprise being 5.4%.
The Zacks Consensus Estimate for Atai Life Sciences’ current-year earnings implies a 16.3% improvement from the year-ago reported figure. It has witnessed four upward estimate revisions over the past month against no movement in the opposite direction. ATAI beat earnings estimates in two of the last four quarters, met once and missed on one occasion.